|
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER
Pursuant
to Rule 13a-16 or 15d-16 of the
Securities
Exchange Act of 1934
For
the month of April 2012
FRESENIUS MEDICAL CARE
AG & Co. KGaA
(Translation
of registrant's name into English)
Else-Kröner
Strasse 1
61346
Bad Homburg
Germany
(Address
of principal executive offices)
Indicate by check mark
whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
S
Form 40-F
£
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
£
Indicate by check mark
if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
£
Indicate
by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
£
No
S
If “Yes” is
marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82
On April 26, 2012 Fresenius Medical Care AG & Co. KGaA (the “Company”) issued an Investor
News announcing
its preliminary results for the first quarter of 2012.
EXHIBITS
|
Exhibit 99.1
|
Investor News issued April 26, 2012.
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
DATE:
April 26, 2012
|
|
Fresenius Medical
Care AG & C
o. KGaA,
|
|
|
a partnership limited by shares, represented by:
|
|
|
|
|
|
fresenius medical
care management ag
, its general partner
|
|
|
|
|
|
|
|
By:
|
/s/
Dr. Ben J. Lipps
|
|
|
|
Name:
|
Dr. Ben J. Lipps
|
|
|
|
Title:
|
Chief Executive Officer and
Chairman of the Management Board of the General Partner
|
|
|
|
|
|
|
|
By:
|
/s/
Michael Brosnan
|
|
|
|
Name:
|
Michael Brosnan
|
|
|
|
Title:
|
Chief Financial Officer and
Member of the Management Board of the General Partner
|
| 
